SCHMC

Attenuated FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for the Koreans (Asian population) with gemcitabine-resistant or –refractory advanced pancreatic cancer

Metadata Downloads
All Author(s)
S. C. Lee ; J. H. Kim ; S. Y. Oh ; K. Kim ; S. Y. Song ; N. Lee ; E. M. I. Nam ; S. Lee ; I. G. Hwang ; H. R. Lee ; J. H. Won ; K. T. Lee ; S. B. Bae ; H. Kim ; H. J. Kim ; J. Jang ; D. H. Lim ; H. W. Lee ; J. H. Kang
Intsitutional Author(s)
이상철; 이규택; 배상병; 김한조
Issued Date
2016
Type
Conference
Conference Name
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference Date
42524
dc_citation_conferenceCountry
Chicago, IL, United States
Citation Publisher
American Society of Clinical Oncology
Citation Title
Journal of Clinical Oncology. Volume 34, Number 15_suppl
Citation Start Page
e15731
Citation End Page
e15731
Language(ISO)
eng
DOI
10.1200/JCO.2016.34.15_suppl.e15731
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/4547
Appears in Collections:
종양혈액내과 > 2. Conference Papers
공개 및 라이선스
  • 공개 구분공개
  • 엠바고Forever
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.